Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InfuSystem Holdings (INFU) Receivables (2016 - 2025)

InfuSystem Holdings (INFU) has disclosed Receivables for 16 consecutive years, with $22.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Receivables rose 8.25% year-over-year to $22.9 million, compared with a TTM value of $22.9 million through Dec 2025, up 8.25%, and an annual FY2025 reading of $22.9 million, up 8.25% over the prior year.
  • Receivables was $22.9 million for Q4 2025 at InfuSystem Holdings, down from $24.3 million in the prior quarter.
  • Across five years, Receivables topped out at $24.5 million in Q2 2025 and bottomed at $14.7 million in Q1 2021.
  • Average Receivables over 5 years is $19.2 million, with a median of $19.2 million recorded in 2023.
  • The sharpest move saw Receivables decreased 6.55% in 2021, then increased 20.75% in 2023.
  • Year by year, Receivables stood at $15.4 million in 2021, then grew by 9.52% to $16.9 million in 2022, then grew by 17.54% to $19.8 million in 2023, then grew by 6.68% to $21.2 million in 2024, then increased by 8.25% to $22.9 million in 2025.
  • Business Quant data shows Receivables for INFU at $22.9 million in Q4 2025, $24.3 million in Q3 2025, and $24.5 million in Q2 2025.